Skip to main content
COAG logo

COAG · Hemab Therapeutics Holdings, Inc. · Debt

Track COAG — free
$38.71 -0.45 (-1.14%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.83B
Shares
46.73M
Volume · Nov 19 43.99K Avg daily vol (3M) 496.12K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 462,000 10-Q filed 2026-11-10
Noncurrent operating lease liabilities 2026-09-30 USD 503,000 10-Q filed 2026-11-10
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 2114044 CUSIP 423494103 13F (30d) 89 filings 88 filers Visit website Investor relations